RXRX

Recursion Pharmaceuticals, Inc.

• TipRanks·4h ago

  Largest borrow rate increases among liquid names

• Simply Wall St·5d ago

  Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)?

• Simply Wall St·6d ago

  A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge

• Benzinga·03/31 13:05

  Citeline Announces Expanded Strategic Partnership With Recursion, Advancing AI-Enabled ClinTech Platform

• Seeking Alpha·03/31 10:35

  Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names

• TipRanks·03/25 21:07

  Recursion Pharmaceuticals Names New Chief Medical Officer

• Reuters·03/25 20:37

  Recursion Pharmaceuticals director Christopher Gibson drops 40,000 common shares; disposal totals $130,000

• Simply Wall St·03/25 17:11

  New Recursion CMO Puts Oncology Experience At Center Of Investor Focus

• Seeking Alpha·03/25 12:44

  Recursion names Vicki Goodman as CMO

• TipRanks·03/25 12:06

  Recursion Pharmaceuticals announces Vicki Goodman as chief medical officer

• Reuters·03/25 11:59

  Recursion names Vicki Goodman chief medical officer effective April 6, 2026; David Mauro exits after about three years

• Reuters·03/25 11:59

  RECURSION PHARMACEUTICALS INC - APPOINTS VICKI GOODMAN AS CHIEF MEDICAL OFFICER EFFECTIVE APRIL 6, 2026

• Simply Wall St·03/23 20:06

  Assessing Recursion Pharmaceuticals (RXRX) Valuation After Prolonged Share Price Weakness

• Reuters·03/18 21:53

  Recursion Pharmaceuticals CFO Ben R Taylor disposes of USD 51,000 in common shares

• Simply Wall St·03/12 06:21

  A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress